Dr. Sheng Xiao, PhD
Head of Autoimmune, Inflammatory, and Infectious Disease Platform In Vivo Pharmacology, Immunology, Inflammatory Disease, Autoimmune Disease
Dr. Sheng Xiao is an accomplished immunologist and drug discovery leader with extensive expertise in inflammation, autoimmune diseases, and tumor immunotherapy. He holds a PhD in Immunology from Boston University, and completed postdoctoral training as well as served as a faculty member at Harvard Medical School. He is currently the Head of the Autoimmune, Inflammatory, and Infectious Disease Platform at WuXi AppTec. With a strong background in in vivo pharmacology and translational science, Dr. Xiao has a proven track record of advancing novel therapies from target discovery through IND-enabling studies. He is recognized for his strategic leadership in driving cross-functional collaborations across academia, biotech, and pharma to accelerate drug discovery programs addressing unmet medical needs. Dr. Xiao has authored over 50 publications in high-impact journals.